NCT04738409

Brief Summary

The objective was

  1. 1.to check whether serum androgen levels and concomitant metabolic changes, oxidative stress and inflammation in adolescent girls with hyperandrogenism may be related to diet.
  2. 2.to identify the factors that increase the risk of being overweight and of obesity among adolescents with clinical features of PCOS, related to diet and DEA (Disordered Eating Attitudes)
  3. 3.to investigate the relationships between markers of oxidation and markers of Systemic Inflammation and macronutrients intake
  4. 4.to assess the relation between oral health of girls with PCOS (including condition of periodontium and dental caries) and their dietary habits, hormonal, metabolic and oxidative and inflammatory status.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2018

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

January 21, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 4, 2021

Completed
4.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

December 8, 2023

Status Verified

December 1, 2023

Enrollment Period

2.4 years

First QC Date

January 21, 2021

Last Update Submit

December 1, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Blood parameters

    Hormonal and biochemical parameters, including follicle-stimulating hormone (FSH), luteinizing hormone (LH), total testosterone, androstenedione, estradiol, dehydroepiandrosterone (DHEA-S), Sex Hormone Binding Globulin (SHBG), fasting glucose and fasting insulin, total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG), 17 OH-Progesterone, Prolactin, Cortisol, Thyroid-stimulating hormone (TSH), will be measured in the morning after overnight fasting.

    2018-2022

  • Anthropometric Assessment

    Body mass index BMI: derived from measured body height (m) and body weight (kg) as body weight / height². Weight will be measured to the nearest 0.1 kg using digital medical scales. Height will be measured with a stadiometer attached to the scales. Waist circumference (WC) will be measured to the nearest 0.1 mm using anthropometric tape between the lower border of rib margin and the upper border of iliac crest (WC-mid).

    2018-2022

  • Body Composition

    Body composition will be assessed with a body composition analyzer (BIA method). The measurements of fat mass (FM) will be expressed as a percentage (%) and kilograms (kg).

    2018-2022

Other Outcomes (6)

  • Disordered Eating Attitudes

    2018-2022

  • Inflammation and Oxidative Stress

    2018-2022

  • Nutrition evaluation

    2018-2022

  • +3 more other outcomes

Study Arms (3)

Ov/Ob group

EXPERIMENTAL

PCOS subjects (Overweight/Obesity)

Other: Lifestyle interventionOther: Effects of AIDiet intervention to improve diet quality, immuno-metabolic health in normal and overweight PCOS girls

N group

EXPERIMENTAL

PCOS subjects (Normal weight)

Other: Lifestyle interventionOther: Effects of AIDiet intervention to improve diet quality, immuno-metabolic health in normal and overweight PCOS girls

H group

NO INTERVENTION

Healthy control subjects

Interventions

The purpose of the research is to evaluate the potential of a multidimensional lifestyle program for PCOS girls. The primary aim is to verify the effectiveness of a 16-week AID intervention vs. HCD (combined with PA\&T), in terms of improvement in androgens level and immune-metabolic risk parameters

N groupOv/Ob group

The purpose of the intervention is to evaluate the effectiveness of the anti-inflammatory diet (AIDiet) among normal weight (N) and overweight/obese (Ov/Ob) women with PCOS.

N groupOv/Ob group

Eligibility Criteria

Age13 Years - 18 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • clinical and/or biochemical hyperandrogenism (hirsutism with moderate to severe acne, and/or elevation of serum total testosterone or free testosterone,
  • oligoovulation (based on oligomenorrhea defined as bleeding episodes occurring less than 8 times per year or secondary amenorrhea),
  • polycystic ovarian picture in an ultrasound examination (at least 12 follicles in each ovary each measuring 2-9 mm in diameter and/or ovarian volume \>10 mL).

You may not qualify if:

  • any systemic disease, thyroid dysfunction, diabetes, congenital adrenal hyperplasia, Cushing syndrome, hyperprolactinemia suggestive of pituitary adenoma and androgen-secreting tumors
  • medications of continuous use,
  • the use of hormonal therapy or antibiotics in the past three months,
  • vitamin or supplements use,
  • alcohol consumption
  • smoking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Poznan University of Medical Sciences

Poznan, 61-701, Poland

Location

Poznan University of Physical Education

Poznan, 61-871, Poland

Location

Related Publications (4)

  • Mizgier M, Wieckowska B, Formanowicz D, Lombardi G, Brozek A, Nowicki M, Durkalec-Michalski K, Kedzia W, Jarzabek-Bielecka G. Effects of AIDiet intervention to improve diet quality, immuno-metabolic health in normal and overweight PCOS girls: a pilot study. Sci Rep. 2024 Feb 12;14(1):3525. doi: 10.1038/s41598-024-54100-1.

  • Mizgier M, Watrowski R, Opydo-Szymaczek J, Jodlowska-Siewert E, Lombardi G, Kedzia W, Jarzabek-Bielecka G. Association of Macronutrients Composition, Physical Activity and Serum Androgen Concentration in Young Women with Polycystic Ovary Syndrome. Nutrients. 2021 Dec 24;14(1):73. doi: 10.3390/nu14010073.

  • Mizgier M, Jarzabek-Bielecka G, Formanowicz D, Jodlowska-Siewert E, Mruczyk K, Cisek-Wozniak A, Kedzia W, Opydo-Szymaczek J. Dietary and Physical Activity Habits in Adolescent Girls with Polycystic Ovary Syndrome (PCOS)-HAstudy. J Clin Med. 2021 Aug 5;10(16):3469. doi: 10.3390/jcm10163469.

  • Mizgier M, Jarzabek-Bielecka G, Wendland N, Jodlowska-Siewert E, Nowicki M, Brozek A, Kedzia W, Formanowicz D, Opydo-Szymaczek J. Relation between Inflammation, Oxidative Stress, and Macronutrient Intakes in Normal and Excessive Body Weight Adolescent Girls with Clinical Features of Polycystic Ovary Syndrome. Nutrients. 2021 Mar 10;13(3):896. doi: 10.3390/nu13030896.

MeSH Terms

Conditions

Polycystic Ovary Syndrome

Condition Hierarchy (Ancestors)

Ovarian CystsCystsNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesGonadal DisordersEndocrine System Diseases

Study Officials

  • Małgorzata Mizgier, PhD

    Poznan University of Phisical Education, Dietetic Department

    PRINCIPAL INVESTIGATOR
  • Justyna Opydo-Szymaczek, PhD

    Poznan University of Medical Scienses

    PRINCIPAL INVESTIGATOR
  • Grażyna Jarząbek-Bielecka, PhD

    Poznan University of Medical Scienses

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

January 21, 2021

First Posted

February 4, 2021

Study Start

April 1, 2018

Primary Completion

September 1, 2020

Study Completion

December 31, 2025

Last Updated

December 8, 2023

Record last verified: 2023-12

Locations